{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:05:25Z","timestamp":1793210725045,"version":"4.5.0"},"reference-count":26,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Musculoskeletal"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pulmonary hypertension associated with systemic sclerosis (SSc-PH) carries a significant risk of mortality. Although interstitial lung disease (ILD) often coexists with SSc-PH, its impact on prognosis varies considerably depending on disease extension. The prognostic implications of different degrees of functional impairment secondary to ILD in patients with SSc-PH remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study aimed to stratify patients with SSc-PH according to their functional parameters and to identify potential prognostic factors in different patterns of ILD extension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A retrospective study was conducted on consecutive patients with SSc-PH diagnosed according to the European Society of Cardiology\/European Respiratory Society guidelines for PH since 2015, from two Italian Scleroderma Centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients were classified according to high-resolution computed tomography (HRCT) findings and forced vital capacity (FVC) values as pulmonary arterial hypertension (PAH) without ILD, PH-ILD with FVC \u2a7e70%, or FVC &lt;70%. Survival analysis, clinical outcomes, and prognostic factors were assessed by Kaplan\u2013Meier curves, multivariate logistic regression, and receiver operating characteristic (ROC) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fifty-three patients with SSc-PH were enrolled, and their 5-year overall survival rate was 66.7%. The 29 patients with PH-ILD demonstrated significantly lower survival than the 24 patients with PAH (48% vs 87%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.005). FVC &lt;70% was associated with markedly reduced survival (29% vs 80% for FVC \u2a7e70%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.003). ROC analysis confirmed FVC as a significant prognostic marker (area under the curve\u2009=\u20090.713,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.005). Multivariate analysis identified the FVC &lt;70% at PH diagnosis as the only significant predictor of mortality. Moreover, PH-ILD patients with FVC &lt;70% showed the most significant functional deterioration during follow-up, with a 19% decline in FVC and a greater deterioration in World Health Organization functional class.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>An FVC &lt;70% at baseline represents an important negative prognostic factor in patients with SSc-PH, independently of the extension of ILD on HRCT scan. Functional assessment may complement radiological evaluation and emphasize the importance of routine monitoring of lung function for risk stratification in patients with SSc-PH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1759720x251410681","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:36:22Z","timestamp":1768844182000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5686-0127","authenticated-orcid":false,"given":"Claudia","family":"Iannone","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy"},{"name":"UOC Clinica Reumatologica, ASST Gaetano Pini\u2014CTO, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Stano","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Pellico","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy"},{"name":"UOC Clinica Reumatologica, ASST Gaetano Pini\u2014CTO, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cito","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Capodiferro","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy"},{"name":"UOC Clinica Reumatologica, ASST Gaetano Pini\u2014CTO, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7479-4462","authenticated-orcid":false,"given":"Fabio","family":"Cacciapaglia","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy"},{"name":"Department of Medicine and Surgery, LUM University \u201cGiuseppe De Gennaro\u201d Casamassima &amp; Rheumatology Service \u201cMiulli\u201d General Hospital Acquaviva delle Fonti, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1549-8852","authenticated-orcid":false,"given":"Nicoletta","family":"Del Papa","sequence":"additional","affiliation":[{"name":"UOC Clinica Reumatologica, ASST Gaetano Pini\u2014CTO, Piazza Cardinal Ferrari 1, Milan 20122, Italy"},{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S191418"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2396"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2016.01.002"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.05.002"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.08.013"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae166"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03059-x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200706-877OC"},{"key":"e_1_3_4_13_2","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy EC","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202\u2013205.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181577654"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02311-2021"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.38029"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.2.344"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200806-953OC"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00678-2018"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14030295"},{"key":"e_1_3_4_22_2","article-title":"Systemic sclerosis-associated interstitial lung disease: diagnostic approaches and challenges","volume":"31","author":"Fairley JL","year":"2024","unstructured":"Fairley JL, Goh NSL, Nikpour M. Systemic sclerosis-associated interstitial lung disease: diagnostic approaches and challenges. Rev Colomb Reumatol 2024; 31: S15\u2013S25.","journal-title":"Rev Colomb Reumatol"},{"key":"e_1_3_4_23_2","article-title":"The analysis of prognostic factors in patients with interstitial lung diseases","volume":"46","author":"Shiraki A","year":"2015","unstructured":"Shiraki A, Ando M, Abe T, et al. The analysis of prognostic factors in patients with interstitial lung diseases. Eur Respir J 2015; 46: PA4863.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.00002915"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203301"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21433"}],"container-title":["Therapeutic Advances in Musculoskeletal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X251410681","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1759720X251410681","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X251410681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:40:25Z","timestamp":1777588825000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1759720X251410681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["10.1177\/1759720X251410681"],"URL":"https:\/\/doi.org\/10.1177\/1759720x251410681","relation":{},"ISSN":["1759-720X","1759-7218"],"issn-type":[{"value":"1759-720X","type":"print"},{"value":"1759-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"1759720X251410681"}}